- Home
- VALN vs IIIV Comparison
VALN vs IIIV Comparison
Compare VALN & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- IIIV
- Stock Information
- Founded
- VALN 2012
- IIIV 2012
- Country
- VALN France
- IIIV United States
- Employees
- VALN N/A
- IIIV N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- IIIV EDP Services
- Sector
- VALN Health Care
- IIIV Technology
- Exchange
- VALN Nasdaq
- IIIV Nasdaq
- Market Cap
- VALN 510.7M
- IIIV 612.5M
- IPO Year
- VALN 2021
- IIIV 2018
- Fundamental
- Price
- VALN $6.40
- IIIV $24.71
- Analyst Decision
- VALN Strong Buy
- IIIV Buy
- Analyst Count
- VALN 3
- IIIV 7
- Target Price
- VALN $15.33
- IIIV $29.57
- AVG Volume (30 Days)
- VALN 83.3K
- IIIV 420.4K
- Earning Date
- VALN 05-07-2025
- IIIV 05-08-2025
- Dividend Yield
- VALN N/A
- IIIV N/A
- EPS Growth
- VALN N/A
- IIIV 4907.14
- EPS
- VALN N/A
- IIIV 4.75
- Revenue
- VALN $201,099,222.00
- IIIV $241,651,000.00
- Revenue This Year
- VALN $18.74
- IIIV $5.32
- Revenue Next Year
- VALN $29.26
- IIIV $3.94
- P/E Ratio
- VALN N/A
- IIIV $7.31
- Revenue Growth
- VALN 21.64
- IIIV 5.59
- 52 Week Low
- VALN $3.62
- IIIV $18.77
- 52 Week High
- VALN $9.50
- IIIV $29.80
- Technical
- Relative Strength Index (RSI)
- VALN 48.49
- IIIV 44.54
- Support Level
- VALN $6.18
- IIIV $24.88
- Resistance Level
- VALN $6.54
- IIIV $25.72
- Average True Range (ATR)
- VALN 0.21
- IIIV 1.04
- MACD
- VALN 0.01
- IIIV -0.13
- Stochastic Oscillator
- VALN 54.35
- IIIV 15.47
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About IIIV i3 Verticals Inc.
i3 Verticals Inc offers integrated payment and software solutions to small and medium-sized businesses and organizations in strategic vertical markets. Its operating segment includes Public Sector and Healthcare. The company generates maximum revenue from the Public Sector segment.